Biblio
Zebrafish as a model to assess cancer heterogeneity, progression and relapse. Dis Model Mech. 2014;7(7):755-762.
. Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia. Biomed Pharmacother. 2023;170:116013.
. .